- Case Studies
Research, innovation, safety, reliability and highest quality standards are the basic requirements for successful chemical & pharmaceutical companies.
The long-term future of the chemical & pharmaceutical industry looks positive. A growing world population, whose prosperity is rising and whose life expectancy is increasing, will result in increasing sales of medicines. However, the present situation presents the industry with major challenges. These include rising performance and usability expectations of patients, health insurers and healthcare providers, as well as expiring patents or declining sales and margins.
Companies in the chemical & pharmaceutical industry are currently facing market changes due to new production capacities in the Middle East and the exponentially growing chemical & pharmaceutical industry in China. Competitors in emerging markets have caught up technologically and are now benefiting from low production costs.
Big Data and Business Analytics, Customer Engagement & Commerce and Supply Chain & Logistics solutions ensure that companies in this situation remain competitive and successful in the long term. With their help, market trends can be identified early on, research costs minimized, customer expectations met, long-term customer relationships profitably secured and logistics and production processes optimized. Our industry solutions enable chemical & pharmaceutical companies to establish a company-wide integrated control system for planning, monitoring, analysis and reporting of all important company processes.
We offer in-depth industry expertise to support manufacturers of chemicals, paints and/or coatings as well as pharmaceuticals and other medical products.
In this way, we help our customers to optimize their business processes, work much more efficiently, identify risks and opportunities more quickly and thus benefit from changes and new challenges.
valantic is your specialist for the chemical & pharmaceutical industry. Ten of the world’s fifteen largest pharmaceutical and biotech companies already trust our expertise. Changing market conditions, new distribution paths, the digitalization of business processes, but also the expiration of medication patents increasingly require new ways of thinking and supporting systems. With valantic’s innovation power and experience, manufacturers in the chemical & pharmaceutical industry can maintain and expand their market position even when basic conditions are changing.
For example, valantic offers a quick, easy evaluation for generation of the necessary information, both for company data as well as for external market data. The crucial tool here is the valantic pharma navigator. With this intelligent advanced analytics solution, relationships can be determined, revealed, analyzed based on scattered company information and this information can be used as the basis for company-strategic decisions.
The analytics suite valantic pharma navigator is an industry solution developed for production and trade in the chemical-pharmaceutical industry. It illustrates all relevant pharma-specific questions and connections.
With the valantic financial pilot, you can easily and quickly create the prerequisites for mapping the structure of an integrated profit and financial planning according to the specifications of your company.
wayRTS is a powerful software for real-time production planning and control of all value-added stages of your company. wayRTS makes your planning transparent and gives you the opportunity to carry out simple interventions with planning support that can be automated as required.
wayMES is the easy-to-use and intuitive instrument for efficient communication between the planning department and internal and external service providers, for example with extended workbenches or suppliers.
Evotec AG is a research-based biotechnical company. It relies on the precise planning of business and research projects. valantic supported the company during the implementation of a new information structure for planning, analysis and reporting with IBM Cognos TM1 and IBM Cognos Business Intelligence. Because of these solutions, Evotec is now able to reliably plan and analyze the business development as well as generate simulations and forecasts.
In our SAP S/4HANA "Deep Dive" workshop, you will get an overview of the relevant innovations, including an individual roadmap with specific recommendations for action. What exactly will change for your business processes?
Boehringer Ingelheim is a German pharmaceutical company. In cooperation with valantic the company redesigned the reporting system from the ground up, created new reports and optimized the design. With the implementation of Cognos 10, the team simultaneously created a new technical basis. This state-of-the-art BI platform does not only allow mobile operations, but also enables report receivers to leave comments thanks to a new comment function attached to the reports.